Stocks›Healthcare›NIVF

NIVF Newgenivf Group Limited

NasdaqResearch view

Newgenivf Group Limited operates in the Services-Misc Health & Allied Services, Nec industry.

$0.279+11.60%
Oct 16 close · 1D EOD · Databento
HealthcareServices-Misc Health & Allied Services, NecMicro-capSEC EDGAR FY 2025-12-31

On the WireNo stories on NIVF yet. Follow the company and the next one lands in Following.

The numbers · FY2025, filed

SEC EDGAR
Market cap$100,750
Revenue$4.7M−13.00%
Net income$9.9M
EPS, diluted$27.36+100.10%
Gross margin20.2%
Operating margin-226.9%
All filed figures

Snapshot

SEC EDGAR · FY 2025-12-31
SectorHealthcare
Market Cap$100,750
Enterprise Value$-657,871
Income$9.9M
Sales$4.7M
Book/sh—
Cash/sh—
Dividend TTM—
Payout—
Employees—
IPO—
Quick Ratio2.98
Current Ratio3.12
Debt/Eq—
EPS (ttm)$27.36
EPS this Y100.1%
EPS past 3/5Y79.6%
Sales past 3/5Y-7.4%
EPS Y/Y TTM100.1%
Sales Y/Y TTM-13.0%
Shs Outstand—
ROA30.2%
ROE38.0%
ROIC-40.4%
Gross Margin20.2%
Oper. Margin-226.9%
Profit Margin209.0%
Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue by fiscal year

$4.1M
FY21
$5.9M
FY22
$5.1M
FY23
$5.4M
FY24
$4.7M
FY25

Operating leverage — margins

GrossOperatingNet
0%110%220%20%-227%209%FY21FY22FY23FY24FY25
Financials, annual · income and cash flowSEC EDGAR · open ▸

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it
USDFY2021FY2022FY2023FY2024FY2025

Same industry

In the screener →

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.